The sensitivity and specificity of EpCAM+CD44+ cell detection to identify patients with GC were 92.3% and 100%, respectively, suggesting that CD44+ CTCs are a candidate biomarker for the detection of GC [52]. Here, EPCAM is linked to gastric cancer.